REMINDER: Our user survey closes TODAY, please submit your responses here.
AstraZeneca and Daiichi’s $4.6bn breast cancer drug breakthrough is good news for all patients. It is almost certain to be a good earner for both companies. SVB Securities analyst Andrew Berens wrote that Enhertu could reach $4.6bn (£3.7bn) sales in HER2-low patients alone by 2030. The drug’s global sales outside of Japan were $426m in 2021.
"At present, AZN is overvalued, and until AZN can start replacing its past blockbuster drug Crestor, this SP will not be continuing its drive higher." What absolute nonsense. Firstly the vaccine though good for public health did and does not turn a profit as it was provided by AZN and the Oxford consortium at cost. Secondly, the income is now rooted firmly in the Oncology pipeline which is immensely strong and a rapidly growing revenue stream as Western (and some Eastern) populations age. The latter was a market forsaken by GSK a move they have now realised was a huge strategic error and are frantically trying to re-enter with some success recently (dostarlimab). Chill out these will be motoring on soon.
EmeraldC. You are wondering why CCL shares are performing so badly:
1. There is a war on
2. Inflation is ripping through incomes and savings, including in the USA
3. Carnival issued 62.5 million shares at $8 per share.
4. Carnival issued $4 billion in three-year senior secured notes paying interest at a rate of 11.5% per year.
5. Carnival issued $1.75 billion in three-year senior convertible notes paying 5.75% per year in interest.
6. In the event that Carnival stock does recover, bondholders will be able to convert their bonds into stock at $10 per share. That's potentially another 175 million shares of stock on the open market, and that will significantly dilute existing shareholders. I could go on..............
" Judging by the amount of advertisements in the UK papers I presume the cruise ships that operate out of the UK will be VERY busy." Not a given. I suspect the volume of advertising is most likely directly proportional to the absolutely desperate scramble for potential bookings!
Profit taking I fancy, as it has had a good run. Core holding for me though, so not selling.
"Spoons in the low 700s is a long term bargain!" Looking at the numbers I would think that it will remain a bargain in the low 700s for some considerable time, maybe into next year. Hardly an enticing prospect given the lack of dividends here.
Got most of those via Investment Trusts but AZN is the star of my S & S ISA bought in the low 30’s . Ever oneards ????
Oh and I forgot to mention that there is NO DIVIDEND. So the reason for staying in here is purely in the hope of capital growth alone (ie. some sort of recovery) with no compensation by way of ongoing income. For long-term holders, as opposed to traders, this now seems a rather forlorn hope. As they say in the bidding room, I'm out.
It is because market sentiment is just that ie. decoupled from the economic reality. It rose because of a belief that the "worst was over" the vaccine had kicked in and hospital admissions had plummeted and everything would quickly return to normal. In truth it was always going to be (and still is) a long slog with respect to Covid19 (Boris wants to magic it away for political reasons, but there were 1,131 deaths involving COVID-19 registered in the UK for the week ending 8 April 2022, an increase from 1,063 deaths in the previous week (ending 1 April 2022) . Then you had the supply chain issues increased energy and labour costs kicking in and now a war and possible full blown recession. That is why the SP is where it is now and may remain so or even drop further in the future.
This board seems to be full of people that go to their local (or more distant) Wetherspoon's only to report that it is "rammed" or "packed' and because of this fleeting anecdotal observation that it follows the company should be making shed-loads of cash and that the SP should be heading north at a rate of knots. You just don't get it do you? Try and understand the fundamentals of the business model, how the company operates, and its associated costs and it might just dawn on you why this is not the case!
Rubbish it is nowt to with any broker/institutional opinion. The reason for the depressed SP is simple economics. All the indicators are negative for a high volume, low margin hospitality business like JDW and there is little that Tim Martin can do about it except complain about his perceived enemies, whether they be in government policy or elsewhere. About as useful as Boris trying to make out that he is not a barefaced liar LOL.
The pubs may be full(ish) but you cannot really judge what the spend is now can you? If people cut back a bit say 3 instead of 4 pints or no starter with a meal you are not going to notice that even by sitting there all day. Spoons, like all other hospitality businesses faces a very tough slog through the coming months. The pubs may stay seemingly full but if average spend falls plus the labour, material, transport and energy costs all rise it just eats into the margins. Simples
Don't worry about Fish'n Chips or pubs mate. Kent will be 80% paved over for lorry parks before long if these clowns in charge have their way LOL.
Focus on City of London Investment Trust. Asked what the trusts worst investment had been John Curtis replied "Carnival, it performed very poorly during the pandemic and had to raise a lot of money. I think the recovery is going to take a very long time, particularly a return to paying dividends. We sold out at a considerable loss."